sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
U.S. Next Generation Diabetes Therapy and Drug Delivery Market by Product Type (Inhalable Insulin, Oral Insulin, Insulin Patch, CGM System, and Artificial Pancreas), Demographic (Adult Population and Child Population), Indication (Type I Diabetes and Type II Diabetes), and End User (Diagnostics/Clinic, ICU, and Home Healthcare) - U.S. Opportunity Analysis and Industry Forecast, 2014-2023

U.S. Next Generation Diabetes Therapy and Drug Delivery Market by...

Home / Categories / Healthcare
U.S. Next Generation Diabetes Therapy and Drug Delivery Market by Product Type (Inhalable Insulin, Oral Insulin, Insulin Patch, CGM System, and Artificial Pancreas), Demographic (Adult Population and Child Population), Indication (Type I Diabetes and Type II Diabetes), and End User (Diagnostics/Clinic, ICU, and Home Healthcare) - U.S. Opportunity Analysis and Industry Forecast, 2014-2023
U.S. Next Generation Diabetes Therapy...
Report Code
RO1/113/1353

Publish Date
07/May/2024

Pages
124
PRICE
$ 3255/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 3910/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 5452/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
TABLE 1. U.S. NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET, BY PRODUCT, 2014-2023 ($THOUSAND)
TABLE 2. U.S. NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET, BY DEMOGRAPHICS, 2014-2023 ($THOUSAND)
TABLE 3. U.S. NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET, BY INDICATION, 2014-2023 ($THOUSAND)
TABLE 4. U.S. NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET, BY END USER, 2014-2023 ($THOUSAND)
TABLE 5. ABBOTT: COMPANY SNAPSHOT
TABLE 6. ABBOTT: OPERATING SEGMENTS
TABLE 7. ABBOTT: PRODUCT PORTFOLIO
TABLE 8. DEXCOM: COMPANY SNAPSHOT
TABLE 9. DEXCOM: PRODUCT PORTFOLIO
TABLE 10. ECHO THERAPEUTICS: COMPANY SNAPSHOT
TABLE 11. ECHO THERAPEUTICS: OPERATING SEGMENTS
TABLE 12. ECHO THERAPEUTICS: PRODUCT PORTFOLIO
TABLE 13. ROCHE: COMPANY SNAPSHOT
TABLE 14. ROCHE: OPERATING SEGMENTS
TABLE 15. ROCHE: PRODUCT PORTFOLIO
TABLE 16. GLYSENS: COMPANY SNAPSHOT
TABLE 17. GLYSENS: PRODUCT PORTFOLIO
TABLE 18. MANNKIND: COMPANY SNAPSHOT
TABLE 19. MANNKIND: PRODUCT PORTFOLIO
TABLE 20. MEDTRONIC: COMPANY SNAPSHOT
TABLE 21. MEDTRONIC: OPERATING SEGMENTS
TABLE 22. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 23. NOVO NORDISK: COMPANY SNAPSHOT
TABLE 24. NOVO NORDISK: OPERATING SEGMENTS
TABLE 25. NOVO NORDISK: PRODUCT PORTFOLIO
TABLE 26. SANOFI: COMPANY SNAPSHOT
TABLE 27. SANOFI: OPERATING SEGMENTS
TABLE 28. SANOFI: PRODUCT PORTFOLIO
TABLE 29. SENSEONICS: COMPANY SNAPSHOT
TABLE 30. SENSEONICS: PRODUCT SEGMENTS
TABLE 31. SENSEONICS: PRODUCT PORTFOLIO
LIST OF FIGURE
FIGURE 1. U.S. NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET: SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS, BY PRODUCT
FIGURE 3. TOP WINNING STRATEGIES, BY YEAR, 2015-2018*
FIGURE 4. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2015-2018* (%)
FIGURE 5. TOP WINNING STRATEGIES, BY COMPANY, 2015-2018*
FIGURE 6. PATENT REGISTERED/APPROVED, BY YEAR
FIGURE 7. PATENT REGISTERED/APPROVED, BY PRODUCT
FIGURE 8. NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET FOR INHALABLE INSULIN, 2014-2023 ($THOUSAND)
FIGURE 9. NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET FOR ORAL INSULIN, 2014-2023 ($THOUSAND)
FIGURE 10. NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET FOR INSULIN PATCH, 2014-2023 ($THOUSAND)
FIGURE 11. NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET FOR CGM SYSTEMS, 2014-2023 ($THOUSAND)
FIGURE 12. NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET FOR ARTIFICIAL PANCREAS, 2014-2023 ($THOUSAND)
FIGURE 13. NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET FOR ADULT POPULATION, 2014-2023 ($THOUSAND)
FIGURE 14. NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET FOR CHILD POPULATION, 2014-2023 ($THOUSAND)
FIGURE 15. NEXT GENERATION TYPE I DIABETES THERAPY AND DRUG DELIVERY MARKET, 2014-2023 ($THOUSAND)
FIGURE 16. NEXT GENERATION TYPE II DIABETES THERAPY AND DRUG DELIVERY MARKET, 2014-2023 ($THOUSAND)
FIGURE 17. NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET FOR DIAGNOSTICS/CLINICS, 2014-2023 ($THOUSAND)
FIGURE 18. NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET FOR ICUS, 2014-2023 ($THOUSAND)
FIGURE 19. NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET FOR HOME HEALTHCARE, 2014-2023 ($THOUSAND)
FIGURE 20. ABBOTT: NET SALES, 2015-2017 ($MILLION)
FIGURE 21. ABBOTT: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 22. ABBOTT: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 23. DEXCOM: NET SALES, 2015-2017 ($MILLION)
FIGURE 24. DEXCOM: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 25. ROCHE: NET SALES, 2015-2017 ($MILLION)
FIGURE 26. ROCHE: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 27. MANNKIND: NET SALES, 2016-2017 ($MILLION)
FIGURE 28. MEDTRONIC: NET SALES, 2015-2017 ($MILLION)
FIGURE 29. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 30. MEDTRONIC: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 31. NOVO NORDISK: NET SALES, 2015-2017 ($MILLION)
FIGURE 32. NOVO NORDISK: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 33. NOVO NORDISK: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 34. SANOFI: NET SALES, 2015-2017 ($MILLION)
FIGURE 35. SANOFI: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 36. SANOFI: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 37. SENSEONICS: NET SALES, 2015-2017 ($MILLION)

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com